NIST grant to fund wireless implant researchThe National Institute of Standards and Technology’s Advanced Technology Program has awarded $1.98 million to Integrated Sensing Systems (ISSYS) to develop wireless, batteryless microfabricated
The National Institute of Standards and Technologys Advanced Technology Program has awarded $1.98 million to Integrated Sensing Systems (ISSYS) to develop wireless, batteryless microfabricated pressure sensors. ISSYS is working on sensors that can provide continuous monitoring of biologic fluid pressures while implanted in the body. Initially, the sensors will be used for hydrocephalus and glaucoma.
The Ypsilanti, MI-based firm produces a pressure sensor the size of a grain of rice, and it intends to extend that products capabilities to a single, self-contained unit that will be powered and read by an external radio-frequency transceiver. The handheld transceiver will be able to detect sensor readings from up to six inches away. The University of Michigans Kellogg Eye Center and the Cleveland Clinic Foundation have agreed to test the products. ISSYS estimates that the devices can save more than $1.5 billion annually in medical testing and treatment.
Study Reaffirms Low Risk for csPCa with Biopsy Omission After Negative Prostate MRI
December 19th 2024In a new study involving nearly 600 biopsy-naïve men, researchers found that only 4 percent of those with negative prostate MRI had clinically significant prostate cancer after three years of active monitoring.
Study Examines Impact of Deep Learning on Fast MRI Protocols for Knee Pain
December 17th 2024Ten-minute and five-minute knee MRI exams with compressed sequences facilitated by deep learning offered nearly equivalent sensitivity and specificity as an 18-minute conventional MRI knee exam, according to research presented recently at the RSNA conference.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.